taswwg

مدونة متخصصة | في مجال التسويق الرقمي | وجميع مجالاته الأفلييت ماركتنج , الدروبشيبنج , التجارة الإلكترونية.

LightBlog

اخبار عاجلة

Axios Pro Rata: Private equity politics — Drug megamerger — So many SPAC

Top of the Morning | Monday, October 05, 2020
 
Axios View in browser
 
Presented By Fidelity
 
Pro Rata
By Dan Primack ·Oct 05, 2020

🎧 Axios Re:Cap on Friday discussed what President Trump's COVID-19 diagnosis means for the White House, the campaign, the markets, and public health policy. Listen via Apple, Spotify, or Axios.

🖥️ You're invited to an Axios virtual event tomorrow at 12:30pm ET on how businesses build capacity for organizational change. Guests are MassMutual CEO Roger Crandall, Clorox chief customer officer Troy Datcher, and Doctor on Demand CEO Hill Ferguson. Register here.

 
 
Top of the Morning
Illustration of Benjamin Franklin with a vote button

Illustration: Eniola Odetunde/Axios

 

Private equity's top trade group is favoring Republicans in next month's federal elections, but is contributing fewer overall dollars than in past cycles.

By the numbers: The American Investment Council PAC has donated over $243,000 to House and Senate candidates and committees since the 2018 elections, of which around 65% has gone to Republicans, according to an Axios analysis of Federal Election Commission records.

  • AIC PAC donated over $405,000 in the 2018 cycle (67% to Republicans) and over $324,000 in the 2016 cycle (58% to Republicans), per OpenSecrets.
  • It has never contributed to presidential candidates of either party, as a matter of policy.
  • A source familiar with the group's donations says that the lower total this cycle reflects fundraising difficulties caused by the pandemic.

Inside the numbers: AIC is betting on status quo when it comes to congressional control.

  • Eight of the nine Senate candidates it supports are Republicans, including Majority Leader Mitch McConnell and threatened incumbents like Susan Collins and Thom Tillis. AIC also donated $30,000 to the National Republican Senatorial Committee, via donations in 2019 and 2020.
  • 22 of the 38 House candidates it supports are Democrats, including Majority Leader Steny Hoyer.
  • AIC has not yet filed its full September report, which is expected show additional donations.

What they're saying: An AIC spokesperson tells Axios: "The AIC PAC contributes to elected officials from both sides of the aisle who support legislation and policies that will encourage more private investment across the country."

  • The spokesperson declined to detail those legislative and policy objectives.
  • AIC's website, however, reflects key priorities as maintaining preferential tax treatment for carried interest and capital gains, maintaining interest deductibility, and CFIUS reforms.

The bottom line: Most private equity contributions to politicians are done on an individual basis, such as Blackstone Group CEO Steve Schwarzman donating over $28 million to President Trump and other GOP causes, but AIC PAC contributions reflect the overall industry's political goals.

Share on Facebook Tweet this Story Post to LinkedIn Email this Story
 
 
The BFD
Illustration of heart monitor charting health care costs

Illustration: Sarah Grillo/Axios

 

Bristol Myers Squibb (NYSE: BMY) agreed to buy MyoKardia (Nasdaq: MYOK), a South San Francisco-based cardiovascular drug developer, for $13.1 billion in cash.

  • Why it's the BFD: This illustrates the diversification downside of last year's $74 billion tie-up with Celgene, which made Bristol Myers heavily reliant on cancer therapies.
  • Pricing: The deal values MyoKardia at $225 per share, representing a 61.2% premium to Friday's closing price.
  • The bottom line: "Bristol Myers gains mavacamten, an experimental heart disease therapy with blockbuster potential. The drug is being tested for treating obstructive hypertrophic cardiomyopathy, a disease where a heart muscle thickens and obstructs blood flow. It affects up to 200,000 people across the U.S. and Europe." — Reuters
Share on Facebook Tweet this Story Post to LinkedIn Email this Story
 
 
Venture Capital Deals

Cooler Screens, a Chicago-based startup that replaces glass doors in store aisle coolers with interactive digital displays, raised $80 million in Series C funding from Verizon Ventures, M12, Great Point Ventures, and SVB. http://axios.link/n6J6

🚑 Your.MD, a London-based maker of the Healthily self-care app, raised $30 million in Series A funding from Reckitt Benckiser. http://axios.link/Yr78

CoreView, an Italy-based Microsoft 365 management platform, raised $10 million led by Insight Partners. www.coreview.com

Engrain, a Denver-based provider of property mapping tech and data visualization software, raised $3.7 million led by RET Ventures. http://axios.link/LYkj

Scener, a Seattle-based co-watching platform for film creators, raised $2.1 million in seed funding. SeaChange led, and was joined by Glaser Investments and Jason Calacanis' Launch. http://axios.link/7z0B

Share on Facebook Tweet this Story Post to LinkedIn Email this Story
 
 

A message from Fidelity

Thematic investing can help you customize your portfolio
 
 

Fidelity's thematic funds cover a range of strategies:

  • Disruption
  • Megatrends
  • Outcome-oriented
  • Differentiated insights
  • Environmental, social, and corporate governance

Explore the opportunities offered by thematic investing to help enhance your portfolio.

Investing involves risk, including risk of loss.
Fidelity Brokerage Services LLC, Member NYSE, SIPC. 904283.2.0
Read additional important information.
 
 
Private Equity Deals

Bain Capital is in exclusive talks to buy British life insurer LV for more than £500 million, per the FT. http://axios.link/RZQT

CC Capital and Motive Partners agreed to buy Wilshire Associates, a Santa Monica, Calif.-based investment tech and advisory firm. http://axios.link/YVxl

LionRock Capital of Hong Kong is in exclusive talks to buy British shoe retailer Clarks, beating out rival bidder Sycamore Partners, per Reuters. A deal could be valued at upwards of £150 million. http://axios.link/Ft1h

Quorum Software, a Houston-based portfolio company of Thoma Bravo, acquired Landdox, a Dallas-based provider of land management software. www.quorumsoftware.com

TA Associates invested in Priority Software, an Israeli EPR software provider whose existing backers include Fortissimo Capital. www.priority-software.com

🚑 Triton has reached out to China's Creat Group Corp. about buying part of its 90% stake in listed German blood plasma company Biotest, per Bloomberg. http://axios.link/AZR3

🚑 VSS Capital Partners invested in Podiatry Growth Partners, a St. Louis-based operator of a national network of regionally branded podiatric clinics. www.podiatry-partners.com

Share on Facebook Tweet this Story Post to LinkedIn Email this Story
 
 
Public Offerings

🚑 Abcam (AIM: ABC), a U.K.-based provider of biological reagents, filed for a $100 million float on the Nasdaq. http://axios.link/SNwU

Aspire Real Estate Investors, a multifamily REIT focused on opportunity zones, filed for a $100 million IPO. It's controlled by Avanath Capital and MacFarlane Partners. http://axios.link/wCK5

🚑 Biodesix, a Boulder, Colo.-based developer of lung disease diagnostics, filed for a $75 million IPO. The pre-revenue plans to list on the Nasdaq (BDSX) with Morgan Stanley and William Blair as lead underwriters, and raised VC funding from firms like Accelerate Diagnostics, Crabtree Ventures, Stericycle, SVB Leerink, and Westfield Capital Management. It also secured a $3.1 million PPP loan. http://axios.link/M2Wr

DraftKings (Nasdaq: DKNG) filed for a secondary public offering whereby it would sell 16 million shares and insiders (including VC backers like Accomplice and Revolution) would sell 16 million shares. At today's opening share price, the total offering could fetch nearly $2 billion. http://axios.link/fno0

🚑 Foghorn Therapeutics, a Cambridge, Mass.-based startup focused on the body's chromatin regulatory system, filed for a $100 million IPO. It plans to list on the Nasdaq (FHTX) with Goldman Sachs as lead underwriter, and recently signed a strategic partnership with Merck that could be valued at up to $425 million. Backers include Flagship Pioneering (44.4% pre-IPO stake) and Seth Klarman's family foundation (7.6%). http://axios.link/uIIN

🚑 Sotera Health, a Broadview Heights, Ohio-based medical sterilization company backed by GTCR and Warburg Pincus, hired JPMorgan to lead an IPO that could value it at more than $5 billion, per Reuters. http://axios.link/Tz1b

Share on Facebook Tweet this Story Post to LinkedIn Email this Story
 
 
SPAC Stuff

🚑 Danimer Scientific, a Bainbridge, Ga.-based bioplastics company backed by VC firms like Advantage Capital, agreed to go public via a reverse merger with Live Oak Acquisition Corp (NYSE: LOAK), a SPAC formed by merchant bank Live Oak. The deal values Danimer at around $890 million. http://axios.link/tZoi

Global Knowledge Training and Skillsoft, both education tech companies, are in talks to merge and simultaneously go public via a reverse merger with Churchill Capital Corp. II, a SPAC led by Michael Klein, per Bloomberg. GKT is a Cary, N.C.-based ed tech company backed by Rhone Capital, while Ireland-based Skillsoft was backed by Charterhouse Capital Partners before its June bankruptcy filing. http://axios.link/p7DK

Romeo Systems, a Vernon, Calif.-based developer of lithium-ion battery modules and packs for commercial electric vehicles, agreed to go public via a reverse merger with RMG Acquisition Corp. (NYSE: RMG), a SPAC led by former Carlyle Group energy investor Robert Mancini. The company would have an initial equity value of $1.33 billion. www.romeopower.com

• Acies Acquisition, a live entertainment-focused SPAC led by former Morgan Stanley bankers Daniel Fetters and Edward King, filed for a $300 million IPO. http://axios.link/RmtR

Atlas Crest Investment Corp, a SPAC formed by Moelis & Co., filed for a $500 million IPO. http://axios.link/OgKe

🚑 BCLS Acquisition, a health care-focused SPAC formed by Bain Capital Life Sciences, filed for a $125 million IPO. http://axios.link/IEG2

Cerberus Telecom Acquisition, a SPAC formed by Cerberus Capital Management, filed for a $400 million IPO. Cerberus first filed for a SPAC in early 2018, but pulled it later that year. http://axios.link/Ruqf

DPCM Capital, a SPAC led by former Uber chief business officer Emil Michael, filed for a $250 million IPO. http://axios.link/lEUP

Lefteris Acquisition, a fintech-focused SPAC led by Mark Casady (co-founder of Vestigo Ventures) and Karl Roessner (ex-CEO of E*Trade), filed for a $225 million IPO. http://axios.link/zawu

Tastemaker Acquisition, a restaurant and hospitality-focused SPAC formed by David Pace (ex-CEO of Jamba and current chair of Red Robin) and Andrew Pfozheimer (co-founder of Barcelona and Bartaco), filed for a $200 million IPO. http://axios.link/P2Ze

Share on Facebook Tweet this Story Post to LinkedIn Email this Story
 
 
Liquidity Events

🚑 Blue Wolf Capital Partners sold PSG, a Plano, Texas-based 340B drug pricing management company, to Omnicell (Nasdaq: OMCL) for $225 million. www.psgconsults.com

MBK Partners is restarting its sale process for Chinese freight forwarder Apex Logistics International, which could fetch more than $1 billion, per Bloomberg. http://axios.link/VeDM

NEC (Tokyo: 6701) agreed to buy Swiss banking software firm Avaloq Group from Warburg Pincus for around $2.2 billion. http://axios.link/85t4

XPO Logistics (NYSE: XPO) is restarting the sale process for its European supply chain unit, which could fetch between $4 billion and $4.5 billion, per Bloomberg. http://axios.link/QSWU

Share on Facebook Tweet this Story Post to LinkedIn Email this Story
 
 
More M&A

Crowdcube and Seedrs, two British equity crowdfunding platforms, agreed to merge. http://axios.link/mEs7

🐄 Fonterra, a New Zealand dairy giant, agreed to sell its China farms for NZ$555 million, via one sale to China Youran Dairy Group and another to Beijing Sanyuan VC. http://axios.link/XDij

Kissner, a Canadian salt producer owned by Stone Canyon Industries, is in advanced talks to buy Morton Salt from German minerals company K+S (DE: SDFG) for around $3.2 billion. http://axios.link/PvE1

Nexi (Milan: NEXII), an Italian payments company, agreed to merge with state-backed rival SIA. The combined company will have around €1.8 billion in annual revenue. http://axios.link/ynzU

TC Energy (TSX: TRP) agreed to buy the 76% stake it doesn't already own in natural gas pipelines operator TC PipeLines (NYSE: TCP) at an enterprise value of around $1.48 billion. http://axios.link/wNMd

Tesla (Nasdaq: TSLA) agreed to buy German battery assembly maker ATW Automation, per Reuters. http://axios.link/84b9

Weir Group (LSE: WEIR) agreed to sell its oil and gas equipment business to Caterpillar (NYSE: CAT) for $405 million in cash. http://axios.link/kj79

Share on Facebook Tweet this Story Post to LinkedIn Email this Story
 
 
Fundraising

SAIF Partners of Hong Kong is raising up to $400 million for its seventh India-focused VC fund, per an SEC filing. www.saifpartners.com

Share on Facebook Tweet this Story Post to LinkedIn Email this Story
 
 
It's Personnel

Sue Siegel, former CEO of GE Ventures, was named chair of The Engine, a hard tech-focused VC firm that spun out of MIT. She succeeds former MIT treasurer Israel Ruiz (who is launching a startup). www.engine.xyz

Share on Facebook Tweet this Story Post to LinkedIn Email this Story
 
 
Final Numbers
Share on Facebook Tweet this Story Post to LinkedIn Email this Story
 
 

A message from Fidelity

A new way to invest in the future of technology
 
 

The Fidelity Disruptive Technology Fund invests in companies using new technology to deliver cloud computing, harness big data, and transform consumer experiences via digital platforms.

Learn more about Fidelity's disruption funds.

Investing involves risk, including risk of loss.
Fidelity Brokerage Services LLC, Member NYSE, SIPC. 904283.2.0
Read additional important information.
 

Thanks for reading Axios Pro Rata! Please ask your friends, colleagues, and congressional candidates to sign up.

 

Axios thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Axios, 3100 Clarendon B‌lvd, Suite 1300, Arlington VA 22201
 
You received this email because you signed up for newsletters from Axios.
Change your preferences or unsubscribe here.
 
Was this email forwarded to you?
Sign up now to get Axios in your inbox.
 

Follow Axios on social media:

Axios on Facebook Axios on Twitter Axios on Instagram